Mice lacking the phosphatase MKP-2 showed reduced cellular senescence in fibroblasts and visceral white adipose tissue, a remodeled adipose lipid profile, improved insulin responsiveness, and extended lifespan. Senescence markers including p16, PAI-1, and phosphorylated p53 were lowered while lamin B1 was preserved, alongside increased hexosylceramides and phosphatidylglycerols and reduced diacylglycerols. The work positions adipose lipid composition as a modifiable input to the pace of biological aging rather than a passive consequence of it.
Key Points
- MKP-2 loss reduced senescence markers in adipose tissue and fibroblasts
- Adipose lipidomics shifted toward hexosylceramides, away from diacylglycerols
- Deficient mice showed better insulin responsiveness and longer lifespan
Longevity Analysis
Visceral fat behaves as a signaling organ, and the species of lipid it stores determines whether it broadcasts inflammatory, senescence-promoting messages or supports metabolic resilience. Diacylglycerol accumulation is a recognized driver of insulin resistance, so its reduction here links a single stress-responsive phosphatase to the quality of fat tissue, the clearance of senescent cells, and the efficiency with which the body converts fuel. Interventions that alter adipose lipid composition — dietary fat quality, visceral fat reduction, insulin-sensitizing practice — plausibly act on the same axis, making this a mechanistic anchor for strategies already available outside the laboratory.
Original published by Wiley Aging Cell, by Morgan Welch, Nabin Ghimire, Shauri Smith, Cassandra Secunda, Alexis Fink, Alissar Sleiman, Laura Chambliss, Christopher Pinckard, Chloe Reyes, Priya Katta, Anna Ai, Benjamin R. Harrison, Ahmed Lawan .